OTC pseudoephedrine, PPA "ordinary" products subject to retail reporting threshold by DEA.
This article was originally published in The Tan Sheet
Executive Summary
OTC PSEUDOEPHEDRINE, PPA "ORDINARY" PRODUCT RETAIL REPORTING THRESHOLD established under proposed implementing regulations to the Comprehensive Methamphetamine Control Act issued by the Drug Enforcement Administration and published in the Federal Register Oct. 7. Under the 1996 law, "ordinary" pseudoephedrine or phenylpropanolamine (PPA) products were exempt from the 24 g single transaction sales reporting trigger required for non-"ordinary" products. "Ordinary" products are defined in the act as those sold in packages not exceeding 3 g pseudoephedrine or PPA base and packaged in blister packs containing no more than two dosage units per blister.